Panacea Life Sciences Holdings, Inc. Derivative, Cost of Hedge
Panacea Life Sciences Holdings, Inc. (PLSH) reported Derivative, Cost of Hedge of $818.36 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DerivativeCostOfHedge · last filed 2018-11-14
- Panacea Life Sciences Holdings, Inc. derivative, cost of hedge for the quarter ending 2018-09-30 was $818.36K, a 289.23% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. derivative, cost of hedge for the quarter ending 2018-06-30 was $119.00K.
- Panacea Life Sciences Holdings, Inc. derivative, cost of hedge for the quarter ending 2018-03-31 was $420.15K.
- Panacea Life Sciences Holdings, Inc. derivative, cost of hedge for the quarter ending 2017-09-30 was $210.25K.
| Period end | Derivative, Cost of Hedge 3 month | Derivative, Cost of Hedge 6 month | Derivative, Cost of Hedge 9 month |
|---|---|---|---|
| 2018-09-30 | $818.36K 10-Q · filed 2018-11-14 | $937.36K derived: sum of 2 quarters · filed 2018-11-14 | $517.21K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $119.00K 10-Q · filed 2018-08-20 | -$301.15K 10-Q · filed 2018-08-20 | |
| 2018-03-31 | $420.15K 10-Q · filed 2018-05-21 | ||
| 2017-09-30 | $210.25K 10-Q · filed 2018-11-14 | $210.25K derived: sum of 2 quarters · filed 2018-11-14 | $210.25K 10-Q · filed 2018-11-14 |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-20 | $0.00 10-Q · filed 2018-08-20 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-21 | ||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-20 | $0.00 10-Q · filed 2017-11-20 |